Article
Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome
24 Feb 2021
Abstract excerpt
Telomere maintenance by telomerase activation or alternative lengthening of telomeres (ALT) is a major determinant of poor outcome in neuroblastoma. Here, we screen for ALT in primary and relapsed neuroblastomas (n = 760) and characterize its features using multi-omics profiling. ALT-positive tumors are molecularly distinct from other neuroblastoma subtypes and enriched in a population-based clinical sequencing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
